Cocrystal Pharma (COCP) Shares Outstanding (2010 - 2026)

Cocrystal Pharma has reported Shares Outstanding (Entity) for 16 years, with the latest figure at $13.8 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 35.51% year-over-year to $13.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.8 million (up 35.51% YoY) and the FY2025 annual result came in at $11.3 million, up 10.97% from the prior year.
• Shares Outstanding (Entity) advanced to $13.8 million in Q1 2026 per COCP's latest filing, from $11.3 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $13.8 million in Q1 2026 and troughed at $8.1 million in Q1 2022.
• A 5-year average of $10.0 million and a median of $10.2 million in 2023 frame the typical range for Shares Outstanding (Entity).
• The widest YoY moves for Shares Outstanding (Entity): up 100158.56% in 2022, down 0.0% in 2022.
• Over 5 years, Shares Outstanding (Entity) stood at $8.1 million in 2022, then advanced by 24.94% to $10.2 million in 2023, then changed by 0.0% to $10.2 million in 2024, then increased by 10.97% to $11.3 million in 2025, then advanced by 22.12% to $13.8 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $13.8 million, $11.3 million, and $13.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.